🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
MAIN STUDY: The purpose of this study is to determine if teriflunomide will...
Status
Completed
Location
Phoenix Neurological Associates, Ltd
Start Date
2013-10
Trial ID
NCT01970410
Treatments Being Tested
The purpose of this study is to evaluate the long-term safety, tolerability...
Status
Terminated
Location
Multiple Locations
Start Date
2004-09
Trial ID
NCT00831649
Treatments Being Tested
The goal of this retrospective observational study is to investigate the lo...
Status
Completed
Location
Multiple Locations
Start Date
2003-01-01
Trial ID
NCT06705608
Treatments Being Tested
The primary objective is to assess the pharmacokinetic (PK) profile of nata...
Status
Completed
Location
Research Site
Start Date
2008-11
Trial ID
NCT00744679
Treatments Being Tested
The primary objective of this study is to assess the efficacy of Ocrelizuma...
Status
Completed
Location
RWJBarnabas Health
Start Date
2017-06-01
Trial ID
NCT03157830
The purpose of this study is to demonstrate the safety, tolerability and cl...
Status
Withdrawn
Location
Multiple Locations
Start Date
2008-12
Trial ID
NCT00801125
Treatments Being Tested
Natalizumab (TYSABRI) is a protein-based drug that is manufactured by Bioge...
Status
Completed
Location
Cleveland Clinic Mellen Center for MS
Start Date
2007-01
Trial ID
NCT00424788
Treatments Being Tested
The purpose of this study is to determine if natalizumab in combination wit...
Status
Completed
Location
Multiple Locations
Start Date
2003-06
Trial ID
NCT00097760
Treatments Being Tested
The primary objective of this study is to demonstrate that the incidence of...
Status
Completed
Location
Research Site
Start Date
2010-03
Trial ID
NCT01070836
Treatments Being Tested
The primary objective of this study is to determine the safety and the immu...
Status
Completed
Location
Performed at only C-1801, C-1802, and C-1803 sites globally. No general public enrollment. Biogen Idec is located in
Start Date
2003-12
Trial ID
NCT00276172
Treatments Being Tested